Literature DB >> 19197939

Severe functional impairment and elevated PD-1 expression in CD1d-restricted NKT cells retained during chronic HIV-1 infection.

Markus Moll1, Carlotta Kuylenstierna, Veronica D Gonzalez, Sofia K Andersson, Lidija Bosnjak, Anders Sönnerborg, Máire F Quigley, Johan K Sandberg.   

Abstract

Invariant CD1d-restricted NKT cells play important roles in regulating both innate and adaptive immunity. They are targeted by HIV-1 infection and severely reduced in number or even lost in many infected subjects. Here, we have investigated the characteristics of NKT cells retained by some patients despite chronic HIV-1 infection. NKT cells preserved under these circumstances displayed an impaired ability to proliferate and produce IFN-gamma in response to CD1d-restricted lipid antigen as compared with cells from uninfected control subjects. HIV-1 infection was associated with an elevated expression of the inhibitory programmed death-1 (PD-1) receptor (CD279) on the CD4(-) subset of NKT cells. However, blocking experiments indicated that the functional defects in NKT cells were largely PD-1-independent. Furthermore, the elevated PD-1 expression and the functional defects were not restored by anti-retroviral treatment, and the NKT cell numbers in blood did not recover significantly in response to treatment. The functional phenotype of NKT cells in these patients suggests an irreversible immune exhaustion due to chronic activation in vivo. The data demonstrate a severe functional impairment in the remaining NKT-cell compartment in HIV-1-infected patients, which limits the prospects to mobilize these cells in immunotherapy approaches in patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197939      PMCID: PMC2736548          DOI: 10.1002/eji.200838780

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  41 in total

1.  Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets.

Authors:  Veronica D Gonzalez; Niklas K Björkström; Karl-Johan Malmberg; Markus Moll; Carlotta Kuylenstierna; Jakob Michaëlsson; Hans-Gustaf Ljunggren; Johan K Sandberg
Journal:  J Immunol Methods       Date:  2007-12-04       Impact factor: 2.303

2.  Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection.

Authors:  Hans J J van der Vliet; B Mary E von Blomberg; Mette D Hazenberg; Nobusuke Nishi; Sigrid A Otto; Birgit H van Benthem; Maria Prins; Frans A Claessen; Alfons J M van den Eertwegh; Giuseppe Giaccone; Frank Miedema; Rik J Scheper; Herbert M Pinedo
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

3.  T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).

Authors:  M D Hazenberg; J W Stuart; S A Otto; J C Borleffs; C A Boucher; R J de Boer; F Miedema; D Hamann
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

4.  Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Valpha24 NKT cell compartment.

Authors:  Johan K Sandberg; Nina Bhardwaj; Douglas F Nixon
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

5.  Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.

Authors:  Johan K Sandberg; Cheryl A Stoddart; Fabienne Brilot; Kimberly A Jordan; Douglas F Nixon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

6.  Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among V alpha 24(+)V beta 11(+) NKT cell subsets with distinct cytokine-producing capacity.

Authors:  Chang H Kim; Brent Johnston; Eugene C Butcher
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

7.  Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.

Authors:  Johan K Sandberg; Noam M Fast; Emil H Palacios; Glenn Fennelly; Joanna Dobroszycki; Paul Palumbo; Andrew Wiznia; Robert M Grant; Nina Bhardwaj; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection.

Authors:  Alison Motsinger; David W Haas; Aleksandar K Stanic; Luc Van Kaer; Sebastian Joyce; Derya Unutmaz
Journal:  J Exp Med       Date:  2002-04-01       Impact factor: 14.307

9.  Distinct functional lineages of human V(alpha)24 natural killer T cells.

Authors:  Peter T Lee; Kamel Benlagha; Luc Teyton; Albert Bendelac
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining.

Authors:  Jenny E Gumperz; Sachiko Miyake; Takashi Yamamura; Michael B Brenner
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

View more
  49 in total

1.  Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection.

Authors:  Seung-Jung Kee; Yong-Soo Kwon; Yong-Wook Park; Young-Nan Cho; Sung-Ji Lee; Tae-Jong Kim; Shin-Seok Lee; Hee-Chang Jang; Myung-Geun Shin; Jong-Hee Shin; Soon-Pal Suh; Dong-Wook Ryang
Journal:  Infect Immun       Date:  2012-03-12       Impact factor: 3.441

2.  Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments.

Authors:  Markus Moll; Sofia K Andersson; Anna Smed-Sörensen; Johan K Sandberg
Journal:  Blood       Date:  2010-06-08       Impact factor: 22.113

Review 3.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

Review 4.  A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application.

Authors:  Taku Okazaki; Shunsuke Chikuma; Yoshiko Iwai; Sidonia Fagarasan; Tasuku Honjo
Journal:  Nat Immunol       Date:  2013-12       Impact factor: 25.606

5.  NF-κB regulates PD-1 expression in macrophages.

Authors:  Alexander P R Bally; Peiyuan Lu; Yan Tang; James W Austin; Christopher D Scharer; Rafi Ahmed; Jeremy M Boss
Journal:  J Immunol       Date:  2015-03-25       Impact factor: 5.422

6.  Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.

Authors:  L C Ndhlovu; J E Snyder-Cappione; K I Carvalho; F E Leal; C P Loo; F R Bruno; A R Jha; D Devita; A M Hasenkrug; H M R Barbosa; A C Segurado; D F Nixon; E L Murphy; E G Kallas
Journal:  Clin Exp Immunol       Date:  2009-09-02       Impact factor: 4.330

Review 7.  A double-edged sword: the role of NKT cells in malaria and HIV infection and immunity.

Authors:  Sandhya Vasan; Moriya Tsuji
Journal:  Semin Immunol       Date:  2009-12-04       Impact factor: 11.130

Review 8.  Biochemical signaling of PD-1 on T cells and its functional implications.

Authors:  Vassiliki A Boussiotis; Pranam Chatterjee; Lequn Li
Journal:  Cancer J       Date:  2014 Jul-Aug       Impact factor: 3.360

9.  Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection.

Authors:  Namita Rout; James G Else; Simon Yue; Michelle Connole; Mark A Exley; Amitinder Kaur
Journal:  PLoS One       Date:  2010-03-24       Impact factor: 3.240

10.  Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy.

Authors:  Sunil K Joshi; Gillian A Lang; Jason L Larabee; T Scott Devera; Lindsay M Aye; Hemangi B Shah; Jimmy D Ballard; Mark L Lang
Journal:  PLoS Pathog       Date:  2009-09-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.